15 Results for "

MIR96

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "MIR96" in MCE Product Catalog:

MIR96-IN-1
MIR96-IN-1
0 Images
Cat. No.: HY-15843
CAS No.: 1311982-88-3
Purity:  99.57%
Target:  

MicroRNA Apoptosis

Research Areas:  

Cancer

MIR96-IN-1 targets the Drosha site in the miR-96 (miRNA-96, microRNA-96) hairpin precursor, inhibiting its biogenesis, derepressing downstream targets, and triggering apoptosis in breast cancer cells. MIR96-IN-1 binds to RNAs with Kds of 1.3, 9.4, 3.4, 1.3 and 7.4 μM for RNA1, RNA2, RNA3, RNA4 and RNA5, respectively . MIR96-IN-1 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
hsa-miR-96-5p mimic
hsa-miR-96-5p mimic
Cat. No.: HY-R02538
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Targaprimir-96
Targaprimir-96
0 Images
Cat. No.: HY-135276
CAS No.: 1655508-14-7
Target:  

MicroRNA Apoptosis

Research Areas:  

Cancer

Targaprimir-96 is a potent inhibitor of microRNA-96 (miR-96) processing. Targaprimir-96 selectively modulates miR-96 production in cancer cells and triggers apoptosis. Targaprimir-96 binds primary miR-96 (pri-miR-96) with low nanomolar affinity. Targaprimir-96 directly engages pri-miR-96 in breast cancer cells and is ineffective on healthy breast cells .
Targaprimir-96 TFA
Targaprimir-96 TFA
0 Images
Cat. No.: HY-135276A
Target:  

MicroRNA Apoptosis

Research Areas:  

Cancer

Targaprimir-96 TFA is a potent inhibitor of microRNA-96 (miR-96) processing. Targaprimir-96 TFA selectively modulates miR-96 production in cancer cells and triggers apoptosis. Targaprimir-96 TFA binds primary miR-96 (pri-miR-96) with low nanomolar affinity. Targaprimir-96 TFA directly engages pri-miR-96 in breast cancer cells and is ineffective on healthy breast cells .
hsa-miR-96-3p mimic
hsa-miR-96-3p mimic
Cat. No.: HY-R02537
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
hsa-miR-96-5p antagomir
hsa-miR-96-5p antagomir
Cat. No.: HY-RI02538A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
rno-miR-96-3p mimic
rno-miR-96-3p mimic
Cat. No.: HY-R04597
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-96-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
hsa-miR-96-3p inhibitor
hsa-miR-96-3p inhibitor
Cat. No.: HY-RI02537
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
hsa-miR-96-5p inhibitor
hsa-miR-96-5p inhibitor
Cat. No.: HY-RI02538
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
rno-miR-96-3p inhibitor
rno-miR-96-3p inhibitor
Cat. No.: HY-RI04597
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-96-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
hsa-miR-96-3p agomir
hsa-miR-96-3p agomir
Cat. No.: HY-R02537A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
hsa-miR-96-5p agomir
hsa-miR-96-5p agomir
Cat. No.: HY-R02538A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
rno-miR-96-3p agomir
rno-miR-96-3p agomir
Cat. No.: HY-R04597A
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-96-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
hsa-miR-96-3p antagomir
hsa-miR-96-3p antagomir
Cat. No.: HY-RI02537A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-96-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
rno-miR-96-3p antagomir
rno-miR-96-3p antagomir
Cat. No.: HY-RI04597A
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-96-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
  • 1
Assay Types